Novartis: Alcon surgical system gets CE mark.
(CercleFinance.com) - Alcon, the eye care division of Novartis, said on Friday that it has achieved European CE mark for a delivery system providing a more precise intraocular lens (IOL) insertion during cataract surgery.
The "Clareon AutonoMe" system is expected to be commercially available to cataract surgeons in the EU early next year, Alcon said in a statement.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The "Clareon AutonoMe" system is expected to be commercially available to cataract surgeons in the EU early next year, Alcon said in a statement.
Copyright (c) 2017 CercleFinance.com. All rights reserved.